Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.

Blood 2016 08 6;128(5):667-79. Epub 2016 Jun 6.

Myeloma Unit, Department of Clinical and Experimental Medicine, and Hematology and BMT Center, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; CoreLab, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy;

The importance of glutamine (Gln) metabolism in multiple myeloma (MM) cells and its potential role as a therapeutic target are still unknown, although it has been reported that human myeloma cell lines (HMCLs) are highly sensitive to Gln depletion. In this study, we found that both HMCLs and primary bone marrow (BM) CD138(+) cells produced large amounts of ammonium in the presence of Gln. MM patients have lower BM plasma Gln with higher ammonium and glutamate than patients with indolent monoclonal gammopathies. Interestingly, HMCLs expressed glutaminase (GLS1) and were sensitive to its inhibition, whereas they exhibited negligible expression of glutamine synthetase (GS). High GLS1 and low GS expression were also observed in primary CD138(+) cells. Gln-free incubation or treatment with the glutaminolytic enzyme l-asparaginase depleted the cell contents of Gln, glutamate, and the anaplerotic substrate 2-oxoglutarate, inhibiting MM cell growth. Consistent with the dependence of MM cells on extracellular Gln, a gene expression profile analysis, on both proprietary and published datasets, showed an increased expression of the Gln transporters SNAT1, ASCT2, and LAT1 by CD138(+) cells across the progression of monoclonal gammopathies. Among these transporters, only ASCT2 inhibition in HMCLs caused a marked decrease in Gln uptake and a significant fall in cell growth. Consistently, stable ASCT2 downregulation by a lentiviral approach inhibited HMCL growth in vitro and in a murine model. In conclusion, MM cells strictly depend on extracellular Gln and show features of Gln addiction. Therefore, the inhibition of Gln uptake is a new attractive therapeutic strategy for MM.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-690743DOI Listing
August 2016
98 Reads

Publication Analysis

Top Keywords

cd138+ cells
12
gln
11
cell growth
8
gln uptake
8
extracellular gln
8
myeloma cells
8
monoclonal gammopathies
8
cells
7
gln glutamate
4
glutamate anaplerotic
4
anaplerotic substrate
4
profile analysis
4
analysis proprietary
4
depleted cell
4
cell contents
4
contents gln
4
substrate 2-oxoglutarate
4
gln gene
4
consistent dependence
4
dependence cells
4

References

(Supplied by CrossRef)
Multiple myeloma.
Anderson et al.
Hematol Oncol Clin North Am 2014
Multiple myeloma.
Palumbo et al.
N Engl J Med 2011
Hyperammonemic encephalopathy in multiple myeloma.
Furer et al.
Isr Med Assoc J 2007

Similar Publications